Ignite Creation Date:
2025-12-18 @ 5:35 AM
Ignite Modification Date:
2025-12-23 @ 10:00 PM
Study NCT ID:
NCT00759408
Status:
None
Last Update Posted:
2018-11-27 00:00:00
First Post:
2008-09-24 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Role of Endothelin in Pulmonary Hypertension
Sponsor:
None
Organization:
Study Overview
Official Title:
The Role of Endothelin in Pulmonary Hypertension
Status:
None
Status Verified Date:
2018-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Endothelin levels are increased in patients with pulmonary hypertension. We wish to compare the effect of an endothelin antagonist on pulmonary hypertension due to a variety of causes.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: